Cargando…

Ginger supplementation for the treatment of non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials

INTRODUCTION: The efficacy of ginger supplementation remains controversial for non-alcoholic fatty liver disease. We conduct this meta-analysis to explore the influence of ginger supplementation versus placebo on the treatment of non-alcoholic fatty liver disease. METHODS: We have searched PubMed, E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Qun, Peng, Ying, Chen, Fangyuan, Dai, Jianbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Makerere Medical School 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398503/ https://www.ncbi.nlm.nih.gov/pubmed/37545930 http://dx.doi.org/10.4314/ahs.v23i1.65

Ejemplares similares

Effect of Ginger Powder Supplementation in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial
por: Rafie, Roya, et al.
Publicado: (2020)

Omega-3 polyunsaturated fatty acid supplementation and non-alcoholic fatty liver disease: A meta-analysis of randomized controlled trials
por: Yan, Jian-Hui, et al.
Publicado: (2018)

Ginger Supplementation in Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
por: Rahimlou, Mehran, et al.
Publicado: (2016)

The effects of supplementation of probiotics, prebiotics, or synbiotics on patients with non-alcoholic fatty liver disease: A meta-analysis of randomized controlled trials
por: Xing, Wenmin, et al.
Publicado: (2022)

Effects of Resveratrol Supplementation in Patients with Non-Alcoholic Fatty Liver Disease—A Meta-Analysis
por: Jakubczyk, Karolina, et al.
Publicado: (2020)

Empagliflozin for the treatment of non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials
por: Tang, Xue, et al.
Publicado: (2022)

Physical activity intervention for non-diabetic patients with non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials
por: Wang, Shu-ting, et al.
Publicado: (2020)

Efficacy of Resveratrol Supplementation against Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Placebo-Controlled Clinical Trials
por: Zhang, Chongyang, et al.
Publicado: (2016)

Effects of Omega-3 Polyunsaturated Fatty Acid Supplementation on Non-Alcoholic Fatty Liver: A Systematic Review and Meta-Analysis
por: Lee, Cheng-Han, et al.
Publicado: (2020)

Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials
por: He, Xi-Xi, et al.
Publicado: (2016)

Combination of the effect of ginger and anti‐inflammatory diet on children with obesity with nonalcoholic fatty liver disease: A randomized clinical trial
por: Kamari, Negin, et al.
Publicado: (2023)

Nigella sativa supplementation and non-alcoholic fatty liver disease: A systematic review of clinical trials
por: Mohtashamian, Abbas, et al.
Publicado: (2023)

Effects of vitamin D supplementation on liver fibrogenic factors in non-alcoholic fatty liver patients with steatohepatitis: study protocol for a randomized clinical trial
por: Ebrahimpour-Koujan, Soraiya, et al.
Publicado: (2019)

Effects of Oral Vitamin C Supplementation on Liver Health and Associated Parameters in Patients With Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial
por: He, Zhangya, et al.
Publicado: (2021)

Ginger-derived nanoparticles protect against alcohol-induced liver damage
por: Zhuang, Xiaoying, et al.
Publicado: (2015)

Effects of Probiotic and Prebiotic Supplementation on Leptin, Adiponectin, and Glycemic Parameters in Non-alcoholic Fatty Liver Disease: A Randomized Clinical Trial
por: Behrouz, Vahideh, et al.
Publicado: (2017)

Effect of Lycium barbarum polysaccharide supplementation in non-alcoholic fatty liver disease patients: study protocol for a randomized controlled trial
por: Gao, Lu-Lu, et al.
Publicado: (2021)

Effect of omega-3 supplementation on cardiometabolic indices in diabetic patients with non-alcoholic fatty liver disease: a randomized controlled trial
por: Sangouni, Abbas Ali, et al.
Publicado: (2021)

The effects of vitamin B12 supplementation on metabolic profile of patients with non-alcoholic fatty liver disease: a randomized controlled trial
por: Talari, Hamid Reza, et al.
Publicado: (2022)

Does Turmeric/curcumin Supplementation Change Anthropometric Indices in Patients with Non-alcoholic Fatty Liver Disease? A Systematic Review and Meta-analysis of Randomized Controlled Trials
por: Jafarirad, Sima, et al.
Publicado: (2019)

Vitamin D Supplementation and Non-Alcoholic Fatty Liver Disease: Present and Future
por: Barchetta, Ilaria, et al.
Publicado: (2017)

Effects of Oral Ginger Supplementation on the INR
por: Rubin, Daniel, et al.
Publicado: (2019)

Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid Supplementation
por: Yang, Jinchunzi, et al.
Publicado: (2019)

Effects of Folic Acid Supplementation on Liver Enzymes, Lipid Profile, and Insulin Resistance in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial
por: Molaqanbari, Mohamad Reza, et al.
Publicado: (2023)

A hypocaloric high-protein diet supplemented with β-cryptoxanthin improves non-alcoholic fatty liver disease: a randomized controlled trial
por: Haidari, Fatemeh, et al.
Publicado: (2020)

Correction to: Effect of Lycium barbarum polysaccharide supplementation in non-alcoholic fatty liver disease patients: study protocol for a randomized controlled trial
por: Gao, Lu-Lu, et al.
Publicado: (2021)

Functional foods and dietary supplements in the management of non-alcoholic fatty liver disease: A systematic review and meta-analysis
por: Wang, Lei-lei, et al.
Publicado: (2023)

Inositol and Non-Alcoholic Fatty Liver Disease: A Systematic Review on Deficiencies and Supplementation
por: Pani, Arianna, et al.
Publicado: (2020)

A randomized controlled trial comparing effects of a low-energy diet with n-3 polyunsaturated fatty acid supplementation in patients with non-alcoholic fatty liver disease
por: Shojasaadat, Fatemeh, et al.
Publicado: (2019)

Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver
por: Foroughi, Mehdi, et al.
Publicado: (2016)

Impact of advanced liver fibrosis on atrial fibrillation recurrence after ablation in non-alcoholic fatty liver disease patients
por: Wang, Zhe, et al.
Publicado: (2022)

Maternal One-Carbon Supplement Reduced the Risk of Non-Alcoholic Fatty Liver Disease in Male Offspring
por: Peng, Hui, et al.
Publicado: (2022)

Omega-3 fatty acids for treatment of non-alcoholic fatty liver disease: design and rationale of randomized controlled trial
por: Janczyk, Wojciech, et al.
Publicado: (2013)

Inflammatory markers response to citrulline supplementation in patients with non-alcoholic fatty liver disease: a randomized, double blind, placebo-controlled, clinical trial
por: Darabi, Zahra, et al.
Publicado: (2019)

Effects of naringenin supplementation in overweight/obese patients with non-alcoholic fatty liver disease: study protocol for a randomized double-blind clinical trial
por: Naeini, Fatemeh, et al.
Publicado: (2021)

The effects of zinc supplementation on the metabolic factors in patients with non-alcoholic fatty liver disease: a randomized, double-blinded, placebo-controlled clinical trial
por: Rezaei, Seyed Mohammad Amin, et al.
Publicado: (2023)

Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism
por: Wang, Songsong, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease
por: Sattar, Naveed, et al.
Publicado: (2014)

Non-alcoholic fatty liver disease
por: Neuschwander-Tetri, Brent A.
Publicado: (2017)

Alcohol? Not for Non-alcoholic Fatty Liver Disease Patients
por: Cainelli, Francesca, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b628f7t6qu9d3bldn07nmmveju